Natco Pharma Limited — Board Meeting, 08-07-2026: Outcome of Board Meeting
08-07-2026 | 12:05 pm
08-07-2026 | 12:05 pm
NATCO Pharma's board approved two key moves: a ₹1400 Cr investment in its South Africa subsidiary and increasing its stake in Adcock Ingram (South Africa) from 35.75% to 49% for ₹1069 Cr. This expands its Africa footprint.
No comments yet. Be the first to comment!
